Back to Journals » Neuropsychiatric Disease and Treatment » Beneath the surface: genetic factors in schizophrenia
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4193)
- Volume 20, 2024 (86)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Journal Articles:
- Autism, the disorder without borders and geopolitical variations (4)
- Beneath the surface: genetic factors in schizophrenia (3)
- Epileptic disorders: advances in the diagnostic and therapeutic strategies (2)
- The effectiveness of non-pharmacological interventions for people with cognitive dysfunction (1)
- Stroke and neurorestoratology (1)
- Suicide Prevention and Intervention: Recent Evidence and Future Directions (4)
- Family and Peer Facilitated/Led Interventions for Severe Mental Health Problems (2)
- Therapeutic Response to Psychedelic Therapy – Who, What, Why & How? (3)
- Current Perspectives of Chronic Stress: from Neurobiology to Treatment (3)
- Issues and Solutions in Autism Spectrum Disorders (ASD) (9)
- Cariprazine in schizophrenia (5)
- The Caregiver Perspective on Pediatric ADHD (3)
- Volume 7 - Supplement 1 (5)
- Volume 6 - Supplement 1 (6)
Beneath the surface: genetic factors in schizophrenia
There are a multitude of potential reasons behind the onset of schizophrenia. While some may explain the condition through external factors, such as drug use or trauma, this Thematic Series considers the potential causes lying low beneath our own genetic material. It has been suggested that certain individuals could be predisposed to schizophrenia, potentially through family members or diathesis-stress models. Treatments therefore have the potential to be adapted to an individual based on genetics, as the influence of pharmacogenomics spreads further into neuropsychiatric illnesses. Therefore, genetics may be able to reveal answers about the origins of schizophrenia, but also the best treatment methods for patients.
Ensemble Learning for Higher Diagnostic Precision in Schizophrenia Using Peripheral Blood Gene Expression Profile
Wagh VV, Kottat T, Agrawal S, Purohit S, Pachpor TA, Narlikar L, Paralikar V, Khare SP
Neuropsychiatric Disease and Treatment 2024, 20:923-936
Published Date: 3 May 2024
Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia
Cao Y, Xu Y, Xia Q, Shan F, Liang J
Neuropsychiatric Disease and Treatment 2023, 19:1455-1462
Published Date: 23 June 2023
Genetic Susceptibility to Tardive Dyskinesia and Cognitive Impairments in Chinese Han Schizophrenia: Role of Oxidative Stress-Related and Adenosine Receptor Genes
Jiang Q, Zhang X, Lu X, Li Y, Lu C, Chi J, Ma Y, Shi X, Wang L, Li S
Neuropsychiatric Disease and Treatment 2023, 19:2499-2509
Published Date: 20 November 2023